- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ADAC's Lowe passes CEO title to Eckert
ADAC Laboratories has added CEO to Andrew Eckert's list of titles, which already includes president and COO. Giving up the CEO mantle is David Lowe, who will remain chairman of the Milpitas, CA, nuclear medicine vendor. ADAC said the transition was part
ADAC Laboratories has added CEO to Andrew Eckert's list of titles, which already includes president and COO. Giving up the CEO mantle is David Lowe, who will remain chairman of the Milpitas, CA, nuclear medicine vendor. ADAC said the transition was part of a long-planned management development strategy, and that Lowe will continue to develop the company's strategic and operating plans.
In other ADAC news, the company signed an agreement to provide multivendor service and support of gamma cameras to customers in the asset management program of independent service organization COHR. The agreement will add over 75 gamma cameras to ADAC's multivendor service effort, which ADAC began in 1995 with the acquisition of JD Technical Services (SCAN 12/13/95).
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
